bonnie rup: unwanted immunogenicity risk in biotherapeutic discovery and development
Published 7 years ago • 298 plays • Length 37:51Download video MP4
Download video MP3
Similar videos
-
51:40
valerie quarmby: assessing immunogenicity risk in biotherapeutic development
-
36:47
robin thorpe: european regulatory guidance for unwanted immunogenicity
-
35:21
tim hickling: applying in vitro immunogenicity assays to predict clinical immunogenicity
-
33:11
tim hickling: application of immunogenicity prediction and mitigation for biotherapeutic development
-
14:24
the finance of immunogenicity
-
5:59
evaluating immunogenicity risk of complex peptide products
-
36:09
susan kirshner fda: therapeutic proteins: routes of exposure and the risk of immunogenicity
-
5:46
role of immunohistochemical markers chromogranin a and synaptophysin: a retrospective analysis
-
58:18
immunomechanism in antibody mediated central nervous system disorders
-
25:32
amy rosenberg: immunogenicity in the time of covid-19
-
16:08
andrew isidoridy: evaluating immunogenicity risk of complex peptide products
-
36:50
tim hickling: contribution of ex vivo assays to immunogenicity risk assessment
-
57:48
david wraith: unwanted immunogenicity: the design and development of tolerogenic t cell epitopes
-
32:21
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
56:55
jeremy fry: tools and technologies for immunogenicity risk management
-
45:14
jeremy fry: tools and technologies for comprehensive immunogenicity risk management
-
28:14
jeremy fry: an integrated approach to managing immunogenicity risk and optimum protein design
-
54:59
jeremy fry: mastering immunogenicity: tools and technologies
-
29:19
sophie tourdot: non-clinical immunogenicity risk assessment of therapeutic proteins
-
41:31
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
0:39
rejuvi 'a' renewal complex - skincare overview with nerida joy